AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15509637
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE, 100 mg im weekly) + levonorgestrel (LNG, 125 microg orally daily)
Trial: 15509637
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE, 100 mg im weekly) + levonorgestrel (LNG, 125 microg orally daily) + dutasteride (0.5 mg orally daily)
Trial: 15509637
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE, 100 mg im weekly) + acyline (300 microg/kg sc every 2 wk)
Trial: 15509637
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE, 100 mg im weekly) + levonorgestrel (LNG, 125 microg orally daily) + acyline (300 microg/kg sc every 2 wk)
Trial: 12523585
Drug: O 20
RxNorm normalized name: ABO 201
DrugBank: ABO-201 (DB17951)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: O 20 mg, clarithromycin (C) 250 mg, metronidazole (M) 500 mg (O.C.M)
Trial: 12523585
Drug: RBC 400
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC 400 mg, clarithromycin (C) 250 mg, metronidazole (M) 500 mg (RBC.C.M)
Trial: 12523585
Drug: RBC 400
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC 400 mg, tetracycline (T) 1000 mg, metronidazole (M) 500 mg (RBC.T.M)
Trial: 10375099
Drug: Chronomodulated 5‐FU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronomodulated 5‐FU (700 mg/m2/day), LV (300 mg/m2/day), and 1‐OHP (25 mg/m2/day) for 4 days every 14 days.
Trial: 1767242
Drug: Aniracetam (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aniracetam (1500 mg/day per os)
Trial: 30665504
Drug: 1 L
RxNorm normalized name: BLUE 1 LAKE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 L of normal saline solution during 1 hour
Trial: 30665504
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution at 10 mL/hour for 1 hour (control group)
Trial: 25274266
Drug: LDRnHBT (Low-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDRnHBT (Low-dose radon hyperthermia balneo treatment)
Trial: 25274266
Drug: Combined hyperthermia
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined hyperthermia balneo and exercise treatment
Trial: 19324944
Drug: Chlorogenic acid
RxNorm normalized name: chlorogenic acid
DrugBank: Chlorogenic Acid (DB12029)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorogenic acid (1 g)
Trial: 19324944
Drug: Trigonelline (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trigonelline (500 mg)
Trial: 19324944
Drug: Placebo (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (1 g mannitol)
Trial: 11522582
Drug: Glatiramer acetate
RxNorm normalized name: Glatiramer Acetate
DrugBank: Glatiramer (DB05259)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glatiramer acetate (GA) 20 mg daily subcutaneous injections
Trial: 3291074
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of diethylcarbamazine (DEC) - 30 mg/kg/d for one week preceded by a one week initial treatment with normal oral doses of DEC or DEC lotion
Trial: 29420189
Drug: DOUBLE (double-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DOUBLE (double-dose clopidogrel)
Trial: 29420189
Drug: TRIPLE (adjunctive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRIPLE (adjunctive cilostazol)
Trial: 29420189
Drug: STANDARD (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: STANDARD (standard dual antiplatelet therapy)
Trial: 24088688
Drug: Integration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integration of family planning services into HIV care and treatment clinics
Trial: 20505750
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of L-NMMA
Trial: 12356000
Drug: Indapamid SR
RxNorm normalized name: Indapamide
DrugBank: Indapamide (DB00808)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indapamid SR 1.5 mg
Trial: 1918848
Drug: Intravenous nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nitroglycerin (1 microgram/kg/min)
Trial: 27091717
Drug: Low-dose corticosteroid
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose corticosteroid prophylaxis (group B, n = 72)
Trial: 27091717
Drug: Low-dose corticosteroid
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose corticosteroid prophylaxis (group B)
Trial: 21039933
Drug: Garlic extract
RxNorm normalized name: Garlic Extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic extract supplementation at 250 mg/kg BW/day/calf
Trial: 16775418
Drug: Docetaxel (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (100 mg/m(2))
Trial: 16775418
Drug: Docetaxel (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (15 mg/m(2)) with ketoconazole (400 mg 3 times daily)
Trial: 11253342
Drug: External compression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External compression with early mobilization and Low Molecular Weight Heparin (LMWH) therapy
Trial: 9189045
Drug: Gabapentin (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (up to 900 mg/day)
Trial: 9189045
Drug: Baclofen (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen (up to 30 mg/day)
Trial: 30457433
Drug: Glycopyrrolate/eFlow CS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate/eFlow CS 50 μg twice daily
Trial: 30457433
Drug: Tiotropium 18 μg
RxNorm normalized name: tiotropium
DrugBank: Tiotropium (DB01409)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 18 μg once daily (administered via HandiHaler™)
Trial: 28544344
Drug: MPH XR-ODT
RxNorm normalized name: MPH
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MPH XR-ODT (60 mg) administered in a fed state
Trial: 28544344
Drug: MPH XR-ODT
RxNorm normalized name: MPH
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MPH XR-ODT (60 mg) administered in a fasted state
Trial: 28544344
Drug: MPH XR-ODT
RxNorm normalized name: MPH
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MPH XR-ODT (60 mg)
Trial: 22353395
Drug: BAY 86-6150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 86-6150 (6.5, 20, 50 or 90 μg kg(‐1))
Trial: 18853615
Drug: Mirazid (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirazid (10 mg/kg for 2 weeks)
Trial: 18853615
Drug: Paromomycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paromomycin (500 mg qid for 2 weeks)
Trial: 18853615
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Mirazid (10 mg/kg) and Paromomycin (500 mg) for two weeks
Trial: 12827065
Drug: Anticoagulants (general)
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulants (general)
Trial: 10669150
Drug: Daily 2
RxNorm normalized name: CVS Oil-Free Daily 2% Acne Wash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily 2 mg micronised oestradiol (E2)
Trial: 10669150
Drug: Daily 2
RxNorm normalized name: CVS Oil-Free Daily 2% Acne Wash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily 2 mg micronised oestradiol combined with a progestagen for 14 days of each cycle (E2+P)
Trial: 10669150
Drug: Daily 2
RxNorm normalized name: CVS Oil-Free Daily 2% Acne Wash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily 2 mg micronised oestradiol (E2) and E2+P
Trial: 8797400
Drug: Albuterol and
RxNorm normalized name: Albuterol and cromolyn only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol and ipratropium (2.5 mg albuterol + 0.5 mg ipratropium)
Trial: 8797400
Drug: Albuterol alone
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol alone (2.5 mg)
Trial: 1468911
Drug: Tizanidine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tizanidine (6 mg/day, increased to 18 mg/day based on response)
Trial: 3979577
Drug: Low-dose danazol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose danazol (100 mg/24 hours)
Trial: 31746880
Drug: High protein
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High protein treatments (both ratios)
Trial: 16214825
Drug: High-risk group
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-risk group defined by ITPA 94C > A or TPMT <10 nmol/(mL erythrocytes . h)
Trial: 9783399
Drug: Inactivated trivalent
RxNorm normalized name: influenza virus vaccine, inactivated trivalent intradermal suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated trivalent influenza split vaccine (IIV)
Trial: 9783399
Drug: Live trivalent
RxNorm normalized name: influenza virus vaccine, live trivalent nasal spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live trivalent influenza allantoic vaccine (LIV)
Trial: 9783399
Drug: Inactivated trivalent
RxNorm normalized name: influenza virus vaccine, inactivated trivalent intradermal suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated trivalent influenza split vaccine (IIV) alone
Trial: 9783399
Drug: Live trivalent
RxNorm normalized name: influenza virus vaccine, live trivalent nasal spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live trivalent influenza allantoic vaccine (LIV) alone
Trial: 8072991
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (600 mg and 1200 mg daily)
Trial: 8072991
Drug: Sugar-reducing drugs
RxNorm normalized name: Invert Sugar
DrugBank: Invert sugar (DB09344)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugar-reducing drugs and insulin
Trial: 3383879
Drug: Molsidomine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine (8 mg)
Trial: 27403645
Drug: saxagliptin 5
RxNorm normalized name: sAXagliptin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: saxagliptin 5 mg/d
Trial: 24606097
Drug: Cholecalciferol (40,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol (40,000 IU weekly)
Trial: 19825207
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g dark chocolate with 500 mg polyphenols
Trial: 19825207
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g dark chocolate with 1000 mg polyphenols
Trial: 19825207
Drug: Both doses
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both doses of dark chocolate
Trial: 9689420
Drug: Sustained release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained release tablet (40 mg)
Trial: 9689420
Drug: Reference preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference preparation (20 mg)
Trial: 7857348
Drug: Pidotimod (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pidotimod (400 mg ampoule twice a day)
Trial: 2776821
Drug: verapamil-SR 360
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil-SR 360 mg once daily
Trial: 2776821
Drug: verapamil-IR 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil-IR 120 mg t.i.d.
Trial: 2776821
Drug: verapamil-SR 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil-SR 240 mg
Trial: 29143926
Drug: Moisturizer plus
RxNorm normalized name: ALCOHOL 0.7 L in 1 L TOPICAL GEL [Fusoni Hand Sanitizer with Moisturizer Plus]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moisturizer plus body wash (twice daily moisturizer and once daily body wash)
Trial: 29143926
Drug: Body wash
RxNorm normalized name: Olay Body Wash
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Body wash alone (once daily)
Trial: 19371267
Drug: Atorvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (10 mg day(-1))
Trial: 19371267
Drug: Pravastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (10 mg day(-1))
Trial: 17029278
Drug: BTX type
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BTX type A (BTX‐A) plus a specific program of physical therapy (BTX‐PT)
Trial: 11394701
Drug: Heparin lock
RxNorm normalized name: Heparin Lock Flush
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heparin lock
Trial: 8098788
Drug: Gln TPN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gln TPN (parenteral nutrition enriched with glycyl‐L‐glutamine)
Trial: 8098788
Drug: STPN (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: STPN (standard parenteral nutrition)
Trial: 3548350
Drug: Suramin (0.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suramin (0.5, 1.0, or 1.5 g weekly for up to six months)
Trial: 29480316
Drug: 0.2 g
RxNorm normalized name: methionine 0.2 gram ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 g oat β-glucan (OBG)
Trial: 29480316
Drug: 0.4 g
RxNorm normalized name: psyllium 0.4 GM Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 g oat β-glucan (OBG)
Trial: 29480316
Drug: 1.6 g
RxNorm normalized name: GLYCERIN 1241.6 g in 1 L TOPICAL LIQUID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.6 g oat β-glucan (OBG)
Trial: 29480316
Drug: Instant oatmeal
RxNorm normalized name: OATMEAL
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Instant oatmeal plus 247 g 2% milk (IO)
Trial: 29480316
Drug: Cream of
RxNorm normalized name: Nubasics Soup Cream of Chicken
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream of rice (CR) plus milk
Trial: 27595528
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg of atorvastatin/day for 2 days preoperatively
Trial: 27595528
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of atorvastatin/day for 5‐9 days preoperatively
Trial: 27595528
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg of atorvastatin/day for 5‐9 days preoperatively
Trial: 20519098
Drug: Colchicine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine (0.5 mg/d)
Trial: 20519098
Drug: Prednisolone (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (5 mg/d)
Trial: 10597203
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of biological risk factor analysis and CT staging
Trial: 7489937
Drug: Aspirin 1200
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 1200 mg daily
Trial: 28544128
Drug: Cetuximab with
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Cetuximab with radiation therapy followed by adjuvant cetuximab and irinotecan (5,940 cGy radiation, cetuximab weekly, irinotecan daily for 5 days per week for 2 weeks every 21 days for 30 weeks)
Trial: 25869284
Drug: Continuous dosing
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous dosing of pomalidomide/dexamethasone
Trial: 25869284
Drug: Intermittent dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent dosing of pomalidomide/dexamethasone
Trial: 25869284
Drug: Both dosing
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both dosing regimens (continuous and intermittent)
Trial: 20025778
Drug: Oxytocin (intranasal)
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin (intranasal)
Trial: 17488782
Drug: Slow-release oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release oral misoprostol (800 microg)
Trial: 17488782
Drug: Conventional misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional misoprostol (vaginal or sublingual)
Trial: 7944416
Drug: OK-432 administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OK-432 administered preoperatively via hepatic artery
Trial: 7959572
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment with OK-432)
Trial: 3284269
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg thiopentone
Trial: 3284269
Drug: 2.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg/kg thiopentone
Trial: 2177499
Drug: Low-dose doxycycline
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose doxycycline capsules (administered daily for 2 weeks)
Trial: 2177499
Drug: Placebo capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsules (administered daily for 2 weeks)
Trial: 2177499
Drug: Low-dose doxycycline
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose doxycycline capsules (in vitro exposure)
Trial: 2177499
Drug: Low-dose doxycycline
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose doxycycline capsules (in additional subjects)
Trial: 27711048
Drug: RG7713 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RG7713 (20 mg intravenous dose)
Trial: 15539964
Drug: Rosuvastatin 40
RxNorm normalized name: rosuvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 40 mg monotherapy
Trial: 15539964
Drug: ER niacin
RxNorm normalized name: Leader Niacin 500mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ER niacin 2 g monotherapy
Trial: 15539964
Drug: Rosuvastatin 10
RxNorm normalized name: rosuvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 10 mg plus ER niacin 2 g
Trial: 15539964
Drug: Rosuvastatin 10
RxNorm normalized name: rosuvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 10 mg plus ER niacin 0.5-2 g
Trial: 15539964
Drug: Rosuvastatin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin monotherapy
Trial: 3309752
Drug: Meclofenamate (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meclofenamate (single dose)
Trial: 27717113
Drug: 4 months
RxNorm normalized name: leuprolide 30 mg/4 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 months healing time before implant placement
Trial: 27717113
Drug: 6 months
RxNorm normalized name: leuprolide 45 mg/6 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 months healing time before implant placement
Trial: 25560227
Drug: 6× weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6× weekly in-center hemodialysis (frequent HD)
Trial: 25560227
Drug: 6× weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6× weekly nocturnal hemodialysis (frequent HD)
Trial: 25560227
Drug: 3× weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3× weekly hemodialysis (conventional HD)
Trial: 21706221
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose Divalproex sodium (up to 1,500 mg/day)
Trial: 21706221
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose Divalproex sodium (up to 250 mg/day)
Trial: 18448393
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of primary and secondary prevention
Trial: 14550900
Drug: nalbuphine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nalbuphine (2.5 mg) with naloxone (0.2 mg)
Trial: 14550900
Drug: nalbuphine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nalbuphine (2.5 mg)
Trial: 14550900
Drug: nalbuphine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nalbuphine (5 mg) with naloxone (0.4 mg)
Trial: 14550900
Drug: nalbuphine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nalbuphine (2.5 mg) with naloxone (0.4 mg)
Trial: 8693548
Drug: Oral cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cyclosporine microemulsion (mean dose: 5.9 mg/kg/day, range: 3.0‐11.7 mg/kg/day)
Trial: 8693548
Drug: Oral cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cyclosporine microemulsion
Trial: 1860215
Drug: Aspirin (325
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (325 mg, alternate-day)
Trial: 23126676
Drug: Reminiscence therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reminiscence therapy under the Watt's protocol with adaptation to Chinese Culture (six weekly sessions of 90 minutes each)